電気医薬品/生物電気医学の世界市場予測(~2026年):製品別(ペースメーカー、ICD、人工内耳、脳深部刺激療法、脊髄、迷走神経、仙骨神経刺激装置)、用途別(虚血、癲癇)、種類別(植込型、非侵襲的)、エンドユーザー別

◆英語タイトル:Electroceuticals/Bioelectric Medicine Market by Product (Pacemaker, ICD, Cochlear Implant, Deep Brain, Spinal Cord, Vagus, Sacral Nerve Stimulators), Application (Ischemia, Epilepsy), Type (Implantable, Noninvasive), End User - Global Forecast to 2026
◆商品コード:MD4358
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2021年6月18日
◆ページ数:255
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

マーケッツアンドマーケッツ社は電気医薬品/生物電気医学の世界市場規模が2021年168億ドルから2026年215億ドルまで、年平均5.0%成長すると予想しています。本書では、世界の電気医薬品/生物電気医学市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(心臓ペースメーカー・植込型除細動器、脊髄刺激装置、人工内耳、脳深部刺激装置、仙骨神経刺激装置・胃電気刺激装置)分析、種類別(埋込型電気機器、非侵襲的電気機器)分析、エンドユーザー別(病院・クリニック・ASCS、その他)分析、地域別分析、競争状況、企業情報などを整理しました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・電気医薬品/生物電気医学の世界市場規模:製品別(心臓ペースメーカー・植込型除細動器、脊髄刺激装置、人工内耳、脳深部刺激装置、仙骨神経刺激装置・胃電気刺激装置)
・電気医薬品/生物電気医学の世界市場規模:種類別(埋込型電気機器、非侵襲的電気機器)
・電気医薬品/生物電気医学の世界市場規模:エンドユーザー別(病院・クリニック・ASCS、その他)
・電気医薬品/生物電気医学の世界市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The global electroceuticals/bioelectric medicine market is projected to reach USD 21.5 billion by 2026 from USD 16.8 billion in 2021, at a CAGR of 5.0% during the forecast period.”
Market growth is driven by factors such as the increasing investments and funding for research on CRM devices, rising government support & funding for neurological disorders, and the rising geriatric population and subsequent growth in the prevalence of neurological & cardiovascular disorders. On the other hand, the high cost of electroceutical devices and the requirement of high capital investments are the major factors hampering the growth of this market.

“The cochlear implantssegment accounted for the highest growth rate in theelectroceuticalsmarket, by product, during the forecast period.”
Theelectroceuticals market is segmented into cardiac pacemakers & implantable cardioverter defibrillators, spinal cord stimulators, cochlear implants, deep brain stimulators, transcutaneous electrical nerve stimulators, vagus nerve stimulators, sacral nerve stimulators & gastric electrical stimulators, and other electrical stimulators based on product. In 2020, the cochlear implants segment accounted for the highest growth rate in the electroceuticals market.The increasing prevalence of hearing lossis a major factor contributing to the growth of this segment.

“Hospitals, clinics, and ASCs segment accounted for the highest CAGR”
Based on end users, the electroceuticals market is segmented into hospitals, clinics, and ASCs; and other end users. In 2020, the hospitals, clinics, and ASCs segment accounted for the highest growth rate. This can be attributed to theincreasing adoption of electroceutical devices to serve a large patient pool.

“Asia Pacific: The fastest-growing regionelectroceuticals market.”
The global electroceuticals market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period.Factors such as the rising healthcare spending, increasing pharmaceutical research funding, increasing government efforts to increase awareness about early disease detection, expansion of private-sector hospitals to rural areas in various APAC countries, and the presence of high-growth markets in the region are driving the growth of the electroceuticals market in this region.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 40%, Tier 2 – 30%,and Tier 3 -30%
• By Designation: C-level – 27%, D-level – 18%, and Others – 55%
• By Region: North America -51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and the Middle East & Africa – 4%

Lists of Companies Profiled in the Report:
• Medtronic plc (Ireland)
• Boston Scientific Corporation (US)
• Abbott Laboratories, Inc. (US)
• LivaNova PLC (UK)
• Cochlear Ltd. (Australia)
• MicroPort Scientific Corporation (China)
• Sonova Group (Switzerland)
• Nevro Corp. (US)
• Axonics Modulation Technologies, Inc. (US)
• Neuronetics, Inc. (US)
• Second Sight Medical Products, Inc. (US)
• NeuroPace, Inc. (US)
• BIOTRONIK (Germany)
• Medico S.p.A. (Italy)
• Nurotron Biotechnology Co. Ltd. (US)
• MED-EL (Austria)
• AlevaNeurotherapeutics SA (Switzerland)
• NeuroSigma, Inc. (US)
• BioWave Corporation (US)
• Soterix Medical Inc. (US)
• Bioinduction Ltd. (UK)
• GiMer Medical (Taiwan)
• Cefaly (Belgium)
• BioControl Medical (Israel)
• tVNS Technologies GmbH (Germany)

Research Coverage:
This report provides a detailed picture of the global electroceuticalsmarket. It aims at estimating the size and future growth potential of the market across different segments, such as product, type, end user,and region. The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall electroceuticals market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

【レポートの目次】

1 INTRODUCTION 35
1.1 OBJECTIVES OF THE STUDY 35
1.2 MARKET DEFINITION 35
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 36
1.2.2 MARKETS COVERED 36
FIGURE 1 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SEGMENTATION 36
1.2.3 YEARS CONSIDERED FOR THE STUDY 37
1.3 CURRENCY 37
1.4 LIMITATIONS 37
1.5 STAKEHOLDERS 38
1.6 SUMMARY OF CHANGES 38
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
2.2 RESEARCH APPROACH 40
FIGURE 2 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: RESEARCH DESIGN 40
2.2.1 SECONDARY DATA 40
2.2.1.1 Key data from secondary sources 41
2.2.2 PRIMARY DATA 42
2.2.2.1 Key data from primary sources 42
2.2.2.2 Key industry insights 43
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 43
2.3 MARKET SIZE ESTIMATION 44
2.3.1 BOTTOM-UP APPROACH 44
2.3.1.1 Company revenue estimation approach 44
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 44
2.3.1.2 Segmental revenue estimation approach 45
FIGURE 5 BOTTOM-UP APPROACH: SEGMENTAL REVENUE ESTIMATION APPROACH 45
2.3.1.3 CAGR projections 45
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 45
2.3.2 TOP-DOWN APPROACH 46
FIGURE 7 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: TOP-DOWN APPROACH 46
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 47
FIGURE 8 DATA TRIANGULATION METHODOLOGY 47
2.5 ASSUMPTIONS FOR THE STUDY 48
2.6 GROWTH RATE ASSUMPTIONS 48
2.7 LIMITATIONS 49
2.8 RISK ASSESSMENT 49
2.8.1 RISKS ASSESSMENT 49
2.9 COVID-19 HEALTH ASSESSMENT 50
2.10 COVID-19 ECONOMIC ASSESSMENT 50
2.11 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 50
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY 50
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 52
2.12 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ELECTROCEUTICALS/
BIOELECTRIC MEDICINE MARKET 53
3 EXECUTIVE SUMMARY 54
FIGURE 11 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 54
FIGURE 12 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 55
FIGURE 13 ELECTROCEUTICALS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 55
FIGURE 14 ELECTROCEUTICALS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION) 56
4 PREMIUM INSIGHTS 57
4.1 ELECTROCEUTICALS MARKET OVERVIEW 57
FIGURE 15 RISING PREVALENCE OF CARDIOVASCULAR & NEUROLOGICAL
DISORDERS TO DRIVE THE MARKET GROWTH 57
4.2 ELECTROCEUTICALS MARKET SHARE, BY PRODUCT, 2021 VS. 2026 57
FIGURE 16 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026 57
4.3 ELECTROCEUTICALS MARKET SHARE, BY TYPE, 2021 VS. 2026 58
FIGURE 17 IMPLANTABLE ELECTROCEUTICAL DEVICES SEGMENT TO DOMINATE
THE MARKET DURING THE FORECAST PERIOD 58
4.4 ELECTROCEUTICALS MARKET SHARE, BY END USER, 2021 VS. 2026 58
FIGURE 18 HOSPITALS, CLINICS, AND ASCS TO CONTINUE TO DOMINATE THE
MARKET IN 2026 58
4.5 ELECTROCEUTICALS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 59
FIGURE 19 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE ELECTROCEUTICALS MARKET DURING THE FORECAST PERIOD 59
5 MARKET OVERVIEW 60
5.1 INTRODUCTION 60
5.2 MARKET DYNAMICS 60
FIGURE 20 ELECTROCEUTICALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 60
5.2.1 DRIVERS 60
5.2.1.1 Rising geriatric population and subsequent growth in the prevalence of neurological & cardiovascular disorders 60
5.2.1.2 Rising government support & funding for neurological disorders 62
FIGURE 21 FUNDING FOR RESEARCH BY THE NATIONAL INSTITUTES OF HEALTH (US) 62
5.2.1.3 Increasing investments and funding for research on CRM devices 62
5.2.2 RESTRAINTS 63
5.2.2.1 High cost of electroceutical devices 63
5.2.3 OPPORTUNITIES 63
5.2.3.1 Emerging markets 63
5.2.4 CHALLENGES 64
5.2.4.1 The dearth of trained professionals 64
5.2.4.2 Challenges associated with battery life and device replacement 65
5.3 IMPACT OF COVID-19 ON THE ELECTROCEUTICALS/ BIOELECTRIC MEDICINE MARKET 65
5.4 RANGES/ SCENARIOS 67
5.4.1 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET 67
FIGURE 22 DEPENDING ON UNCERTAINTIES, THE FOLLOWING SCENARIOS HAVE BEEN ASSESSED FOR THE ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET 67
5.5 PRICING ANALYSIS 67
TABLE 1 PRICE OF ELECTROCEUTICAL DEVICES (2021) 67
5.6 PATENT ANALYSIS 68
5.6.1 PATENT ANALYSIS OF CARDIAC PACEMAKERS 68
5.6.2 PATENT ANALYSIS OF COCHLEAR IMPLANTS 69
5.7 TRADE ANALYSIS 70
5.7.1 TRADE ANALYSIS FOR PACEMAKERS 70
TABLE 2 IMPORT DATA FOR PACEMAKERS, BY COUNTRY, 2016–2020 (USD MILLION) 70
TABLE 3 EXPORT DATA FOR PACEMAKERS, BY COUNTRY, 2016–2020 (USD MILLION) 70
5.8 VALUE CHAIN ANALYSIS 70
FIGURE 23 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE 71
5.9 SUPPLY CHAIN ANALYSIS 71
FIGURE 24 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 72
5.10 ECOSYSTEM ANALYSIS OF THE ELECTROCEUTICALS/ BIOELECTRIC MEDICINE MARKET 73
FIGURE 25 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET:
ECOSYSTEM ANALYSIS 73
5.10.1 ROLE IN ECOSYSTEM 73
5.11 PORTER’S FIVE FORCES ANALYSIS 74
TABLE 4 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: PORTER’S FIVE FORCES ANALYSIS 74
5.11.1 THREAT OF NEW ENTRANTS 74
5.11.2 THREAT OF SUBSTITUTES 74
5.11.3 BARGAINING POWER OF BUYERS 74
5.11.4 BARGAINING POWER OF SUPPLIERS 74
5.11.5 DEGREE OF COMPETITION 75
5.12 REGULATORY LANDSCAPE 75
5.12.1 NORTH AMERICA 75
5.12.1.1 US 75
5.12.1.2 Canada 75
5.12.2 EUROPE 75
5.12.3 ASIA PACIFIC 75
5.12.3.1 Japan 75
5.12.3.2 India 76
5.12.4 LATIN AMERICA 76
5.12.4.1 Brazil 76
5.12.4.2 Mexico 76
5.12.5 MIDDLE EAST 76
5.13 TECHNOLOGY ANALYSIS 77
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 77
5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR ELECTROCEUTICAL
DEVICES MANUFACTURERS 77
5.14.2 REVENUE SHIFT FOR ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET 78
6 ELECTROCEUTICALS MARKET, BY PRODUCT 79
6.1 INTRODUCTION 80
TABLE 5 ELECTROCEUTICALS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 80
TABLE 6 ELECTROCEUTICALS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 80
6.2 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 81
6.2.1 INTRODUCTION OF LEADLESS AND MRI-SAFE CARDIAC PACEMAKERS
& IMPLANTABLE CARDIOVERTER DEFIBRILLATORS TO BOOST THE
MARKET GROWTH OF THIS SEGMENT 81
TABLE 7 KEY PRODUCTS IN THE CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET 82
TABLE 8 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016–2019 (USD MILLION) 83
TABLE 9 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020–2026 (USD MILLION) 84
6.3 SPINAL CORD STIMULATORS 84
TABLE 10 KEY PRODUCTS IN THE SPINAL CORD STIMULATORS MARKET 85
TABLE 11 SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 85
TABLE 12 SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 85
6.3.1 CHRONIC PAIN 86
6.3.1.1 Spinal cord stimulation (SCS) is the standard procedure for
patients with chronic pain in the back and limbs 86
TABLE 13 SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY REGION, 2016–2019 (USD MILLION) 86
TABLE 14 SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY REGION, 2020–2026 (USD MILLION) 87
6.3.2 FAILED BACK SURGERY SYNDROME 87
6.3.2.1 Introduction of alternative therapies to restrain the market growth 87
TABLE 15 SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2016–2019 (USD MILLION) 88
TABLE 16 SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2020–2026 (USD MILLION) 88
6.3.3 CEREBRAL ISCHEMIA 88
6.3.3.1 High incidence of ischemia to drive the market growth for
spinal cord stimulators 88
TABLE 17 SPINAL CORD STIMULATORS MARKET FOR CEREBRAL ISCHEMIA,
BY REGION, 2016–2019 (USD MILLION) 89
TABLE 18 SPINAL CORD STIMULATORS MARKET FOR CEREBRAL ISCHEMIA,
BY REGION, 2020–2026 (USD MILLION) 89
6.4 COCHLEAR IMPLANTS 90
6.4.1 INCREASING PREVALENCE OF HEARING LOSS TO DRIVE THE MARKET DEMAND FOR COCHLEAR IMPLANTS 90
TABLE 19 KEY DEVICES IN THE COCHLEAR IMPLANTS MARKET 90
TABLE 20 COCHLEAR IMPLANTS MARKET, BY REGION, 2016–2019 (USD MILLION) 91
TABLE 21 COCHLEAR IMPLANTS MARKET, BY REGION, 2020–2026 (USD MILLION) 91
6.5 DEEP BRAIN STIMULATORS 91
TABLE 22 KEY DEVICES IN THE DEEP BRAIN STIMULATORS MARKET 92
TABLE 23 DEEP BRAIN STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 92
TABLE 24 DEEP BRAIN STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 93
6.5.1 PARKINSON’S DISEASE 93
6.5.1.1 The rising incidence of Parkinson’s disease and growing
R&D activities in this field is likely to drive market growth 93
TABLE 25 DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE,
BY REGION, 2016–2019 (USD MILLION) 94
TABLE 26 DEEP BRAIN STIMULATORS MARKET FOR PARKINSON’S DISEASE,
BY REGION, 2020–2026 (USD MILLION) 94
6.5.2 TREMORS 94
6.5.2.1 The high efficiency of DBS in treating tremors has boosted
the market demand for deep brain stimulators 94
TABLE 27 DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY REGION,
2016–2019 (USD MILLION) 95
TABLE 28 DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY REGION,
2020–2026 (USD MILLION) 95
6.5.3 DEPRESSION 95
6.5.3.1 The use of DBS in the treatment of depression is restrained
by a lack of evidence for its efficacy 95
TABLE 29 DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY REGION,
2016–2019 (USD MILLION) 96
TABLE 30 DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY REGION,
2020–2026 (USD MILLION) 96
6.5.4 OTHER DBS APPLICATIONS 97
TABLE 31 DEEP BRAIN STIMULATORS MARKET FOR OTHER DBS APPLICATIONS,
BY REGION, 2016–2019 (USD MILLION) 97
TABLE 32 DEEP BRAIN STIMULATORS MARKET FOR OTHER DBS APPLICATIONS,
BY REGION, 2020–2026 (USD MILLION) 98
6.6 SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS 98
TABLE 33 SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 99
TABLE 34 SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 99
6.6.1 URINARY INCONTINENCE 99
6.6.1.1 High incidence of urinary incontinence to offer growth
opportunities for sacral nerve stimulators 99
TABLE 35 SACRAL NERVE STIMULATORS MARKET FOR URINARY INCONTINENCE,
BY REGION, 2016–2019 (USD MILLION) 100
TABLE 36 SACRAL NERVE STIMULATORS MARKET FOR URINARY INCONTINENCE,
BY REGION, 2020–2026 (USD MILLION) 100
6.6.2 GASTROPARESIS 101
6.6.2.1 Gastric electrical stimulation treatment reduces the hospital
stay duration for patients affected by gastroparesis 101
TABLE 37 GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS,
BY REGION, 2016–2019 (USD MILLION) 101
TABLE 38 GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS,
BY REGION, 2020–2026 (USD MILLION) 101
6.6.3 FECAL INCONTINENCE 102
6.6.3.1 High reductions in symptom recurrence have supported the
use of sacral nerve stimulators in fecal incontinence treatment 102
TABLE 39 SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE,
BY REGION, 2016–2019 (USD MILLION) 102
TABLE 40 SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE,
BY REGION, 2020–2026 (USD MILLION) 103
6.7 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS 103
TABLE 41 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET,
BY APPLICATION, 2016–2019 (USD MILLION) 104
TABLE 42 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET,
BY APPLICATION, 2020–2026 (USD MILLION) 104
6.7.1 TREATMENT-RESISTANT DEPRESSION 104
6.7.1.1 High prevalence of depression to support the market growth 104
TABLE 43 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET
FOR TREATMENT-RESISTANT DEPRESSION, BY REGION,
2016–2019 (USD MILLION) 105
TABLE 44 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET
FOR TREATMENT-RESISTANT DEPRESSION, BY REGION,
2020–2026 (USD MILLION) 105
6.7.2 OTHER TENS APPLICATIONS 105
TABLE 45 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR
OTHER TENS APPLICATIONS, BY REGION, 2016–2019 (USD MILLION) 106
TABLE 46 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR
OTHER TENS APPLICATIONS, BY REGION, 2020–2026 (USD MILLION) 106
6.8 VAGUS NERVE STIMULATORS 107
TABLE 47 VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 107
TABLE 48 VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 107
6.8.1 EPILEPSY 108
6.8.1.1 Advantages associated with VNS in the treatment of epilepsy
are expected to drive the market growth 108
TABLE 49 VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY REGION,
2016–2019 (USD MILLION) 108
TABLE 50 VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY REGION,
2020–2026 (USD MILLION) 109
6.8.2 OTHER VNS APPLICATIONS 109
TABLE 51 VAGUS NERVE STIMULATORS MARKET FOR OTHER VNS APPLICATIONS,
BY REGION, 2016–2019 (USD MILLION) 110
TABLE 52 VAGUS NERVE STIMULATORS MARKET FOR OTHER VNS APPLICATIONS,
BY REGION, 2020–2026 (USD MILLION) 110
6.9 OTHER ELECTRICAL STIMULATORS 111
TABLE 53 OTHER ELECTRICAL STIMULATORS MARKET, BY REGION,
2016–2019 (USD MILLION) 112
TABLE 54 OTHER ELECTRICAL STIMULATORS MARKET, BY REGION,
2020–2026 (USD MILLION) 112
7 ELECTROCEUTICALS MARKET, BY TYPE 113
7.1 INTRODUCTION 114
TABLE 55 ELECTROCEUTICALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 114
TABLE 56 ELECTROCEUTICALS MARKET, BY TYPE, 2020–2026 (USD MILLION) 114
7.2 IMPLANTABLE ELECTROCEUTICAL DEVICES 115
7.2.1 LONG TERM COST SAVINGS ASSOCIATED WITH THE USE OF THESE
DEVICES TO DRIVE THE MARKET GROWTH 115
TABLE 57 IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 116
TABLE 58 IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION,
2020–2026 (USD MILLION) 117
7.3 NONINVASIVE ELECTROCEUTICAL DEVICES 117
7.3.1 EXTENSIVE USE IN HEALTHCARE, EASE OF USE, AND LOW COSTS
TO DRIVE THE MARKET GROWTH FOR NONINVASIVE DEVICES 117
TABLE 59 NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 118
TABLE 60 NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION,
2020–2026 (USD MILLION) 119
8 ELECTROCEUTICALS MARKET, BY END USER 120
8.1 INTRODUCTION 121
TABLE 61 ELECTROCEUTICALS MARKET, BY END USER, 2016–2019 (USD MILLION) 121
TABLE 62 ELECTROCEUTICALS MARKET, BY END USER, 2020–2026 (USD MILLION) 121
8.2 HOSPITALS, CLINICS, AND ASCS 121
8.2.1 GROWING NUMBER OF SURGERIES PERFORMED IN HOSPITALS AND
ASCS TO SUPPORT THE MARKET GROWTH 121
TABLE 63 ELECTROCEUTICALS MARKET FOR HOSPITALS, CLINICS, AND ASCS,
BY REGION, 2016–2019 (USD MILLION) 123
TABLE 64 ELECTROCEUTICALS MARKET FOR HOSPITALS, CLINICS, AND ASCS,
BY REGION, 2020–2026 (USD MILLION) 123
8.3 OTHER END USERS 123
TABLE 65 ELECTROCEUTICALS MARKET FOR OTHER END USERS, BY REGION,
2016–2019 (USD MILLION) 125
TABLE 66 ELECTROCEUTICALS MARKET FOR OTHER END USERS, BY REGION,
2020–2026 (USD MILLION) 125
9 ELECTROCEUTICALS MARKET, BY REGION 126
9.1 INTRODUCTION 127
TABLE 67 ELECTROCEUTICALS MARKET, BY REGION, 2016–2019 (USD MILLION) 127
TABLE 68 ELECTROCEUTICALS MARKET, BY REGION, 2020–2026 (USD MILLION) 127
9.2 NORTH AMERICA 128
FIGURE 26 NORTH AMERICA: ELECTROCEUTICALS MARKET SNAPSHOT 129
TABLE 69 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 130
TABLE 70 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 130
TABLE 71 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 130
TABLE 72 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 131
9.2.1 US 131
9.2.1.1 The US dominated the North American electroceuticals
market in 2020 131
TABLE 73 US: KEY MACROINDICATORS 133
TABLE 74 US: ELECTROCEUTICALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 133
TABLE 75 US: ELECTROCEUTICALS MARKET, BY TYPE, 2020–2026 (USD MILLION) 133
TABLE 76 US: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 134
TABLE 77 US: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 134
TABLE 78 US: SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 135
TABLE 79 US: SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 135
TABLE 80 US: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 135
TABLE 81 US: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 136
TABLE 82 US: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS,
BY APPLICATION, 2016–2019 (USD MILLION) 136
TABLE 83 US: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 136
TABLE 84 US: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET,
BY APPLICATION, 2016–2019 (USD MILLION) 137
TABLE 85 US: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET,
BY APPLICATION, 2020–2026 (USD MILLION) 137
TABLE 86 US: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 137
TABLE 87 US: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 138
TABLE 88 US: ELECTROCEUTICALS MARKET, BY END USER, 2016–2019 (USD MILLION) 138
TABLE 89 US: ELECTROCEUTICALS MARKET, BY END USER, 2020–2026 (USD MILLION) 138
9.2.2 CANADA 139
9.2.2.1 Favorable environment for R&D in cardiology and neurosciences
to drive the market growth 139
TABLE 90 NEUROLOGICAL CONDITIONS IN CANADA 139
TABLE 91 CANADA: ELECTROCEUTICALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 140
TABLE 92 CANADA: ELECTROCEUTICALS MARKET, BY TYPE, 2020–2026 (USD MILLION) 140
TABLE 93 CANADA: ELECTROCEUTICALS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 141
TABLE 94 CANADA: ELECTROCEUTICALS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 141
TABLE 95 CANADA: SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 142
TABLE 96 CANADA: SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 142
TABLE 97 CANADA: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 142
TABLE 98 CANADA: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 143
TABLE 99 CANADA: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016–2019 (USD MILLION) 143
TABLE 100 CANADA: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 143
TABLE 101 CANADA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET,
BY APPLICATION, 2016–2019 (USD MILLION) 144
TABLE 102 CANADA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET,
BY APPLICATION, 2020–2026 (USD MILLION) 144
TABLE 103 CANADA: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 144
TABLE 104 CANADA: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 145
TABLE 105 CANADA: ELECTROCEUTICALS MARKET, BY END USER,
2016–2019 (USD MILLION) 145
TABLE 106 CANADA: ELECTROCEUTICALS MARKET, BY END USER,
2020–2026 (USD MILLION) 145
9.3 EUROPE 146
TABLE 107 EUROPE: ELECTROCEUTICALS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 146
TABLE 108 EUROPE: ELECTROCEUTICALS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 146
TABLE 109 EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 147
TABLE 110 EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 147
9.3.1 GERMANY 148
9.3.1.1 Germany dominated the European electroceuticals market in 2020 148
TABLE 111 GERMANY: KEY MACROINDICATORS 149
TABLE 112 GERMANY: ELECTROCEUTICALS MARKET, BY TYPE,
2016–2019 (USD MILLION) 149
TABLE 113 GERMANY: ELECTROCEUTICALS MARKET, BY TYPE,
2020–2026 (USD MILLION) 149
TABLE 114 GERMANY: ELECTROCEUTICALS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 150
TABLE 115 GERMANY: ELECTROCEUTICALS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 150
TABLE 116 GERMANY: SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 151
TABLE 117 GERMANY: SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 151
TABLE 118 GERMANY: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 151
TABLE 119 GERMANY: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 152
TABLE 120 GERMANY: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016–2019 (USD MILLION) 152
TABLE 121 GERMANY: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 152
TABLE 122 GERMANY: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 153
TABLE 123 GERMANY: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 153
TABLE 124 GERMANY: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 153
TABLE 125 GERMANY: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 154
TABLE 126 GERMANY: ELECTROCEUTICALS MARKET, BY END USER,
2016–2019 (USD MILLION) 154
TABLE 127 GERMANY: ELECTROCEUTICALS MARKET, BY END USER,
2020–2026 (USD MILLION) 154
9.3.2 UK 155
9.3.2.1 Increasing investments and funding by the government to
drive the market growth in the UK 155
TABLE 128 UK: KEY MACROINDICATORS 156
TABLE 129 UK: ELECTROCEUTICALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 156
TABLE 130 UK: ELECTROCEUTICALS MARKET, BY TYPE, 2020–2026 (USD MILLION) 157
TABLE 131 UK: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 157
TABLE 132 UK: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 158
TABLE 133 UK: SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 158
TABLE 134 UK: SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 158
TABLE 135 UK: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 159
TABLE 136 UK: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 159
TABLE 137 UK: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS,
BY APPLICATION, 2016–2019 (USD MILLION) 159
TABLE 138 UK: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 160
TABLE 139 UK: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET,
BY APPLICATION, 2016–2019 (USD MILLION) 160
TABLE 140 UK: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET,
BY APPLICATION, 2020–2026 (USD MILLION) 160
TABLE 141 UK: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 161
TABLE 142 UK: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 161
TABLE 143 UK: ELECTROCEUTICALS MARKET, BY END USER, 2016–2019 (USD MILLION) 161
TABLE 144 UK: ELECTROCEUTICALS MARKET, BY END USER, 2020–2026 (USD MILLION) 161
9.3.3 REST OF EUROPE 162
TABLE 145 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP) 162
TABLE 146 ROE: ELECTROCEUTICALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 163
TABLE 147 ROE: ELECTROCEUTICALS MARKET, BY TYPE, 2020–2026 (USD MILLION) 163
TABLE 148 ROE: ELECTROCEUTICALS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 163
TABLE 149 ROE: ELECTROCEUTICALS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 164
TABLE 150 ROE: SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 164
TABLE 151 ROE: SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 164
TABLE 152 ROE: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 165
TABLE 153 ROE: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 165
TABLE 154 ROE: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016–2019 (USD MILLION) 165
TABLE 155 ROE: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 166
TABLE 156 ROE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET,
BY APPLICATION, 2016–2019 (USD MILLION) 166
TABLE 157 ROE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET,
BY APPLICATION, 2020–2026 (USD MILLION) 166
TABLE 158 ROE: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 167
TABLE 159 ROE: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 167
TABLE 160 ROE: ELECTROCEUTICALS MARKET, BY END USER,
2016–2019 (USD MILLION) 167
TABLE 161 ROE: ELECTROCEUTICALS MARKET, BY END USER, BY APPLICATION,
2020–2026 (USD MILLION) 168
9.4 ASIA PACIFIC 168
FIGURE 27 ASIA PACIFIC: ELECTROCEUTICALS MARKET SNAPSHOT 169
TABLE 162 APAC: ELECTROCEUTICALS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 169
TABLE 163 APAC: ELECTROCEUTICALS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 170
TABLE 164 APAC: ELECTROCEUTICALS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 170
TABLE 165 APAC: ELECTROCEUTICALS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 171
9.4.1 CHINA 171
9.4.1.1 China dominated the APAC market for electroceutical
devices in 2020 171
TABLE 166 CHINA: KEY MACROINDICATORS 172
TABLE 167 CHINA: ELECTROCEUTICALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 172
TABLE 168 CHINA: ELECTROCEUTICALS MARKET, BY TYPE, 2020–2026 (USD MILLION) 172
TABLE 169 CHINA: ELECTROCEUTICALS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 173
TABLE 170 CHINA: ELECTROCEUTICALS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 173
TABLE 171 CHINA: SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 174
TABLE 172 CHINA: SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 174
TABLE 173 CHINA: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 174
TABLE 174 CHINA: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 175
TABLE 175 CHINA: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016–2019 (USD MILLION) 175
TABLE 176 CHINA: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 175
TABLE 177 CHINA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET,
BY APPLICATION, 2016–2019 (USD MILLION) 176
TABLE 178 CHINA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET,
BY APPLICATION, 2020–2026 (USD MILLION) 176
TABLE 179 CHINA: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 176
TABLE 180 CHINA: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 177
TABLE 181 CHINA: ELECTROCEUTICALS MARKET, BY END USER,
2016–2019 (USD MILLION) 177
TABLE 182 CHINA: ELECTROCEUTICALS MARKET, BY END USER, BY APPLICATION, 2020–2026 (USD MILLION) 177
9.4.2 JAPAN 178
9.4.2.1 The elderly population in Japan drives the market growth
for electroceutical devices 178
TABLE 183 JAPAN: KEY MACROINDICATORS 178
TABLE 184 JAPAN: ELECTROCEUTICALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 179
TABLE 185 JAPAN: ELECTROCEUTICALS MARKET, BY TYPE, 2020–2026 (USD MILLION) 179
TABLE 186 JAPAN: ELECTROCEUTICALS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 179
TABLE 187 JAPAN: ELECTROCEUTICALS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 180
TABLE 188 JAPAN: SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 180
TABLE 189 JAPAN: SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 181
TABLE 190 JAPAN: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 181
TABLE 191 JAPAN: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 181
TABLE 192 JAPAN: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016–2019 (USD MILLION) 182
TABLE 193 JAPAN: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 182
TABLE 194 JAPAN: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET,
BY APPLICATION, 2016–2019 (USD MILLION) 182
TABLE 195 JAPAN: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET,
BY APPLICATION, 2020–2026 (USD MILLION) 183
TABLE 196 JAPAN: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 183
TABLE 197 JAPAN: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 183
TABLE 198 JAPAN: ELECTROCEUTICALS MARKET, BY END USER,
2016–2019 (USD MILLION) 184
TABLE 199 JAPAN: ELECTROCEUTICALS MARKET, BY END USER, BY APPLICATION, 2020–2026 (USD MILLION) 184
9.4.3 REST OF ASIA PACIFIC 184
TABLE 200 ROAPAC: ELECTROCEUTICALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 186
TABLE 201 ROAPAC: ELECTROCEUTICALS MARKET, BY TYPE, 2020–2026 (USD MILLION) 186
TABLE 202 ROAPAC: ELECTROCEUTICALS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 186
TABLE 203 ROAPAC: ELECTROCEUTICALS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 187
TABLE 204 ROAPAC: SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 187
TABLE 205 ROAPAC: SPINAL CORD STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 187
TABLE 206 ROAPAC: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 188
TABLE 207 ROAPAC: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 188
TABLE 208 ROAPAC: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016–2019 (USD MILLION) 188
TABLE 209 ROAPAC: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 189
TABLE 210 ROAPAC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET,
BY APPLICATION, 2016–2019 (USD MILLION) 189
TABLE 211 ROAPAC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET,
BY APPLICATION, 2020–2026 (USD MILLION) 189
TABLE 212 ROAPAC: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 190
TABLE 213 ROAPAC: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 190
TABLE 214 ROAPAC: ELECTROCEUTICALS MARKET, BY END USER,
2016–2019 (USD MILLION) 190
TABLE 215 ROAPAC: ELECTROCEUTICALS MARKET, BY END USER, BY APPLICATION, 2020–2026 (USD MILLION) 191
9.5 LATIN AMERICA 191
9.5.1 INCREASING EFFORTS TO IMPLEMENT UNIVERSAL HEALTH COVERAGE
IN THE REGION TO SUPPORT MARKET GROWTH 191
TABLE 216 LATIN AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 192
TABLE 217 LATIN AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 192
9.6 MIDDLE EAST & AFRICA 193
9.6.1 STRENGTHENING OF HEALTHCARE INFRASTRUCTURE IN THE REGION
TO SUPPORT THE MARKET GROWTH 193
TABLE 218 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 194
TABLE 219 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 194
10 COMPETITIVE LANDSCAPE 195
10.1 OVERVIEW 195
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 195
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET 195
TABLE 220 OVERVIEW OF STRATEGIES DEPLOYED BY KEY ELECTROCEUTICAL
DEVICES MANUFACTURING COMPANIES 196
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 198
FIGURE 28 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET 198
10.4 MARKET SHARE ANALYSIS 199
FIGURE 29 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SHARE,
BY KEY PLAYER (2020) 199
TABLE 221 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET:
DEGREE OF COMPETITION 199
10.5 COMPANY EVALUATION QUADRANT 201
10.5.1 LIST OF EVALUATED VENDORS 201
10.5.2 STARS 201
10.5.3 EMERGING LEADERS 201
10.5.4 PERVASIVE PLAYERS 201
10.5.5 PARTICIPANTS 201
FIGURE 30 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 202
10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2020) 202
10.6.1 PROGRESSIVE COMPANIES 202
10.6.2 STARTING BLOCKS 203
10.6.3 RESPONSIVE COMPANIES 203
10.6.4 DYNAMIC COMPANIES 203
FIGURE 31 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2020 203
10.7 COMPETITIVE BENCHMARKING 204
10.7.1 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS 204
FIGURE 32 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS
IN THE ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET 204
TABLE 222 COMPANY PRODUCT TYPE FOOTPRINT 204
TABLE 223 COMPANY GEOGRAPHICAL FOOTPRINT 205
10.8 COMPETITIVE SCENARIO 205
10.8.1 PRODUCT LAUNCHES & REGULATORY APPROVALS 205
TABLE 224 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS 205
10.8.2 DEALS 206
TABLE 225 KEY DEALS 206

11 COMPANY PROFILES 207
11.1 KEY PLAYERS 207
(Business Overview, Products Offered, Recent Developments, MnM view, Key strengths/right to win, Strategic choices made, Weaknesses and competitive threats)*
11.1.1 MEDTRONIC PLC 207
TABLE 226 MEDTRONIC PLC: BUSINESS OVERVIEW 207
FIGURE 33 MEDTRONIC PLC: COMPANY SNAPSHOT (2020) 208
11.1.2 ABBOTT LABORATORIES, INC. 212
TABLE 227 ABBOTT LABORATORIES, INC.: BUSINESS OVERVIEW 212
FIGURE 34 ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT (2020) 213
11.1.3 BOSTON SCIENTIFIC CORPORATION 216
TABLE 228 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 216
FIGURE 35 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020) 217
11.1.4 COCHLEAR LTD. 221
TABLE 229 COCHLEAR LTD.: BUSINESS OVERVIEW 221
FIGURE 36 COCHLEAR LTD.: COMPANY SNAPSHOT (2020) 222
11.1.5 LIVANOVA PLC 224
TABLE 230 LIVANOVA PLC: BUSINESS OVERVIEW 224
FIGURE 37 LIVANOVA PLC: COMPANY SNAPSHOT (2020) 225
11.1.6 MICROPORT SCIENTIFIC CORPORATION 228
TABLE 231 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 228
FIGURE 38 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019) 229
11.1.7 SONOVA GROUP 231
TABLE 232 SONOVA GROUP: BUSINESS OVERVIEW 231
FIGURE 39 SONOVA GROUP: COMPANY SNAPSHOT (2019) 232
11.1.8 NEVRO CORP. 233
TABLE 233 NEVRO CORP.: BUSINESS OVERVIEW 233
FIGURE 40 NEVRO CORP.: COMPANY SNAPSHOT (2020) 233
11.1.9 AXONICS MODULATION TECHNOLOGIES, INC. 235
TABLE 234 AXONICS MODULATION TECHNOLOGIES, INC.: BUSINESS OVERVIEW 235
FIGURE 41 AXONICS MODULATION TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2020) 235
11.1.10 SECOND SIGHT MEDICAL PRODUCTS, INC. 237
TABLE 235 SECOND SIGHT MEDICAL PRODUCTS, INC.: BUSINESS OVERVIEW 237
FIGURE 42 SECOND SIGHT MEDICAL PRODUCTS, INC.: COMPANY SNAPSHOT (2019) 237
11.2 OTHER PLAYERS 238
11.2.1 NEURONETICS, INC. 238
TABLE 236 NEURONETICS, INC.: BUSINESS OVERVIEW 238
FIGURE 43 NEURONETICS, INC.: COMPANY SNAPSHOT (2020) 239
11.2.2 NEUROPACE, INC. 241
TABLE 237 NEUROPACE, INC.: BUSINESS OVERVIEW 241
11.2.3 BIOTRONIK 242
TABLE 238 BIOTRONIK: BUSINESS OVERVIEW 242
11.2.4 MEDICO S.P.A. 244
TABLE 239 MEDICO S.P.A.: BUSINESS OVERVIEW 244
11.2.5 NUROTRON BIOTECHNOLOGY CO. LTD. 245
TABLE 240 NUROTRON BIOTECHNOLOGY CO. LTD.: BUSINESS OVERVIEW 245
11.2.6 MED-EL 246
TABLE 241 MED-EL: BUSINESS OVERVIEW 246
11.2.7 ALEVA NEUROTHERAPEUTICS SA 247
TABLE 242 ALEVA NEUROTHERAPEUTICS SA: BUSINESS OVERVIEW 247
11.2.8 NEUROSIGMA, INC. 248
ABLE 243 NEUROSIGMA, INC.: BUSINESS OVERVIEW 248
11.2.9 BIOWAVE CORPORATION 249
TABLE 244 BIOWAVE CORPORATION: BUSINESS OVERVIEW 249
11.2.10 SOTERIX MEDICAL INC. 250
TABLE 245 SOTERIX MEDICAL INC.: BUSINESS OVERVIEW 250
11.2.11 BIOINDUCTION LTD 251
TABLE 246 BIOINDUCTION LTD: BUSINESS OVERVIEW 251
11.2.12 GIMER MEDICAL 252
TABLE 247 GIMER MEDICAL: BUSINESS OVERVIEW 252
11.2.13 CEFALY 253
TABLE 248 CEFALY: BUSINESS OVERVIEW 253
11.2.14 BIOCONTROL MEDICAL 254
TABLE 249 BIOCONTROL MEDICAL: BUSINESS OVERVIEW 254
11.2.15 TVNS TECHNOLOGIES GMBH 255
TABLE 250 TVNS TECHNOLOGIES GMBH: BUSINESS OVERVIEW 255
*Details on Business Overview, Products Offered, Recent Developments, MnM view, Key strengths/right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX 256
12.1 INSIGHTS FROM INDUSTRY EXPERTS 256
12.2 DISCUSSION GUIDE 257
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 261
12.4 AVAILABLE CUSTOMIZATIONS 263
12.5 RELATED REPORTS 263
12.6 AUTHOR DETAILS 264

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[電気医薬品/生物電気医学の世界市場予測(~2026年):製品別(ペースメーカー、ICD、人工内耳、脳深部刺激療法、脊髄、迷走神経、仙骨神経刺激装置)、用途別(虚血、癲癇)、種類別(植込型、非侵襲的)、エンドユーザー別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆